In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Medical Microbiology

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/00222615-48-12-1087PMID 10591162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ANTIFUNGAL THERAPY IN ‘BONE MARROW FAILURE’

  1998cited by this paper
• Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models

  1998cited by this paper
• Invasive aspergillosis.

  1998cited by this paper
• Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

  1997cited by this paper
• In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.

  1997cited by this paper
• Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

  1997cited by this paper
• Copyright © 1997, American Society for Microbiology Itraconazole Resistance in Aspergillus fumigatus

  1996cited by this paper
• Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model

  1996cited by this paper
• Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

  1996cited by this paper
• Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis

  1995cited by this paper
• Azole drug resistance in yeasts.

  1995cited by this paper
• Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

  1995cited by this paper
• In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

  1992cited by this paper
• Experimental murine invasive pulmonary aspergillosis.

  1990cited by this paper

• Aspergillus fumigatus and aspergillosis: From basics to clinics

  2021cites this paper
• A point mutation in the 14  -sterol demethylase gene cyp51A contributes to the resistance to itraconazole of Aspergillus fumigatus.

  2019cites this paper
• Epsilon-poly-l-lysine decorated ordered mesoporous silica contributes to the synergistic antifungal effect and enhanced solubility of a lipophilic drug.

  2019cites this paper
• The Genome of a Thermo Tolerant, Pathogenic Albino Aspergillus fumigatus

  2018cites this paper
• Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization

  2017cites this paper
• Invasive Aspergillosis in Cancer Patients

  2017cites this paper
• Azole resistance in Aspergillus: epidemiology and surveillance

  2016cites this paper
• The pharmacodynamics of antifungal agents against Aspergillus

  2013cites this paper
• Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.

  2012cites this paper
• The impact of azole resistance on aspergillosis guidelines

  2012cites this paper
• Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature

  2011cites this paper
• Azole Resistance in Aspergillus fumigatus—Current Epidemiology and Future Perspectives

  2011cites this paper
• Azole Antifungal Resistance Today: Focus on Aspergillus

  2011cites this paper
• Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.

  2010cites this paper
• Antifungal mechanisms of action and resistance.

  2009cites this paper
• Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance

  2008cites this paper
• In Vitro Survey of Triazole Cross-Resistance Among More Than 700 Clinical Isolates of

  2008cites this paper
• Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

  2008cites this paper
• In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

  2008cites this paper
• Post-antifungal effects of the antifungal compound 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate on Aspergillus fumigatus.

  2007cites this paper
• Aspergillus fumigatus C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility

  2006cites this paper
• The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.

  2005cites this paper
• Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.

  2005cites this paper
• Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: Difficulties in Establishing Correlation Between In Vitro Susceptibility Data and the Outcome of Initial Amphotericin B Therapy

  2005cites this paper
• Differences in Interactions between Azole Drugs Related to Modifications in the 14-α Sterol Demethylase Gene (cyp51A) of Aspergillus fumigatus

  2005cites this paper
• Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus

  2005cites this paper
• Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

  2004cites this paper
• Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis

  2004cites this paper
• A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus

  2004cites this paper
• Emerging fungal resistance.

  2004cites this paper
• In Vitro Interactions between Amphotericin B, Itraconazole, and Flucytosine against 21 Clinical Aspergillus Isolates Determined by Two Drug Interaction Models

  2004cites this paper
• Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis

  2004cites this paper
• A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus

  2003cites this paper
• Susceptibility testing of fungi--current status and open questions.

  2003cites this paper
• [Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].

  2002cites this paper
• In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.

  2002cites this paper
• Antifungal resistance in pathogenic fungi.

  2002cites this paper
• Azole Cross-Resistance in Aspergillus fumigatus

  2002cites this paper
• Itraconazole — perspectives for the management of invasive aspergillosis

  2002cites this paper
• Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate.

  2002cites this paper
• Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis

  2002cites this paper
• Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos

  2002cites this paper
• Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.

  2001cites this paper
• Membrane and cell wall targets in Aspergillus fumigatus.

  2001cites this paper
• Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

  2001cites this paper
• Acquired itraconazole resistance in Aspergillus fumigatus.

  2001cites this paper
• Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis.

  2000cites this paper
• The role of murine models in the development of antifungal therapy for systemic mycoses.

  2000cites this paper
• The Antifungal Activity of Sulfonylated/Carboxylated Derivatives of Dibenzo-1,4-Dioxine-2-Acetyloxime May Be Due to Inhibition of Lanosterol-14Al-Demethylase

  2000cites this paper
• Invasive aspergillosis.

  2000cites this paper
• Antifungal drug resistance in Aspergillus.

  2000cites this paper
• REVIEW ARTICLE Antifungal Drug Resistance in Aspergillus

  2000cites this paper
• Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.

  1999cites this paper
• Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance �

  year unknowncites this paper